Tag: omnyx

Discussion with CEOs from Inspirata and Omnyx

| February 14, 2018 | 0 Comments

In the wake of the news of Inspirata acquiring Omnyx recently I had an opportunity to speak with the CEOs of each company and get their thoughts. The big question in my mind and those of many readers was “Why Omnyx? Why now?” How did this happen? Below is a summary of our discussion. Perhaps […]

Continue Reading

Inspirata Acquires Omnyx

| January 31, 2018 | 0 Comments

News today from two of the biggest names in digital pathology. In the past six years or so we have seen Roche acquire BioImagene, Aperio get acquired by Leica Biosystems and Philips acquire PathXL. Two of those being examples of large international IVD companies purchasing primarily scanner companies (I realize they both had some workflow […]

Continue Reading

Changes Coming at Omnyx – Developing Story

| July 19, 2016 | 0 Comments

Nearly 10 years ago GE Healthcare and the University of Pittsburgh Medical Center (UPMC)entered into a joint venture. The two organizations began a two year collaboration process and founded the company in 2008. Since that time, close collaboration brought to market new innovations in digital pathology, culminating in Dynamyx (TM), which was demonstrated at USCAP this […]

Continue Reading

FDA’s Technical Performance Assessment of Digital Pathology Whole Slide Imaging Devices

| May 10, 2016 | 0 Comments

WHAT DOES IT MEAN TO ME? The Digital Pathology Association 2016 Webinar Series – Session 2 Available to Members Only Thursday, May 25, 2016 | 1pm EST Learn more about the newly released FDA Guidance for Technical Performance Assessment of Digital Pathology Whole Slide Imaging Devices. What does it mean to you? Members of the DPA […]

Continue Reading

Join Omnyx for a Webinar!

| April 10, 2016 | 0 Comments

Quantification Algorithms: Value and Progress in Standardization of IHC Breast Tissue Data April 13th, 2016 12:00 PM EST Michael Grunkin, Ph.D. Chief Executive Officer Visiopharm In collaboration with Visiopharm®, Dynamyx™ software provides pathologists sophisticated tools that incorporate precision, quantification and confidence in decision-making for breast panel analysis (HER2, ER, PR, Ki67). These algorithms give pathologists […]

Continue Reading

Omnyx, LLC Introduces New Dynamyx™ Software for Exceptional Digital Pathology User Experience

| March 16, 2016 | 0 Comments

I was able to see a demonstration of this new release at USCAP 2016 the other day and there are many improvements over the prior version.  The application still provides a robust worklist with fast response to cases and metadata associated with the case and the virtual slide tray on another monitor.  New features I […]

Continue Reading

Join Omnyx For a Reception at USCAP 2016!

| March 8, 2016 | 0 Comments

Please Join Omnyx for a Reception at USCAP 2016 Celebrating Advances in Digital Pathology Sunday, March 13th, 2016 5:00 PM – 7:00 PM Omnyx invites you to join them for refreshments, networking and insightful conversation with your peers about how digital pathology can enhance cancer care outcomes. At 6 p.m. two leading innovators will be […]

Continue Reading

Digital Pathology Association Acknowledges Collaborative Efforts with FDA for Whole Slide Imaging

| February 20, 2016 | 0 Comments

The Digital Pathology Association (DPA) recently announced its suggestion that digital pathology manufacturers currently interested in marketing Whole Slide Imaging (WSI) devices for primary diagnosis in the United States submit de novo applications to the Food and Drug Administration (FDA) based on clarity and guidance provided to the DPA from the FDA. WSI technology is critical to advancement […]

Continue Reading

Omnyx Applauds FDA and Digital Pathology Association on Recent Collaboration 

| January 17, 2016 | 0 Comments

Last week news was released after months of speculation, that the FDA would consider the de novo classification option for digital pathology systems as a pathway for bringing to market a moderate or low risk device which has not yet been classified, and for which there is no predicate device (as in whole slide imaging systems). If the FDA […]

Continue Reading

Further Rejection of Null Hypothesis: Digital Pathology Equal to Glass Slides

| December 21, 2015 | 0 Comments

Since the inception of commercially available whole slide imaging systems more than 15 years ago, a necessary requirement has been to prove that diagnoses made using DP alone are equal to or better than conventional glass slides (GS) that have been used for at 10 times longer to care for patients. That is to say, […]

Continue Reading

Join Omnyx for a Webinar!

| December 9, 2015 | 0 Comments

Expanding Access to Expertise: UPMC Digital Pathology Consultation Service December 15th, 2015 12:00 PM EST Dr. Liron Pantanowitz Professor of Pathology & Bioinformatics, Director of Pathology Informatics University of Pittsburgh Medical Center, United States UPMC (University of Pittsburgh Medical Center) is a world-renowned health care provider based in Pittsburgh, Pennsylvania. A recognized innovator in information […]

Continue Reading

Omnyx Joins the White House and the American Society for Clinical Pathology to Globalize the Fight Against Cancer

| November 18, 2015 | 0 Comments

Big news today from Omnyx in partnership with the White House Office of Science of Technology Policy, American Society for Clinical Pathology, American Cancer Society, Union International Cancer Control, Sakura, Roche and Pfizer. ASCP pathologists in collaboration with digital pathology and laboratory support will provide pathology consults for patients in Africa.  A great example of […]

Continue Reading

Join Omnyx for a Webinar! An Early Adopter’s Perspective: Expanding Your Use of Digital Pathology

| June 26, 2015 | 0 Comments

An Early Adopter’s Perspective: Expanding Your Use of Digital Pathology July 2nd, 2015 12:00 PM EST Professor Rainer Grobholz Chief of Pathology Department, Aarau Cantonal Hospital Aarau, Switzerland In cancer care, the pathologist provides the definitive diagnosis of cancer and plays a critical role in helping to ultimately determine a patient’s treatment. In order to […]

Continue Reading

New Pan-European Digital Pathology Network Aims to Transform Diagnosis and Treatment of Cancer and Other Diseases

| June 23, 2015 | 0 Comments

A new digital pathology solution allows pathologists to examine tissues in high-resolution on their computer screens from any network location and easily get second opinions Previously pathologists would have to assess physical slides under a microscope and post them by mail for a second opinion. This could result in delays and risk slides being lost […]

Continue Reading